Renalytix Ai Stock Investor Sentiment

RNLX Stock  USD 0.14  0.01  7.69%   
Slightly above 54% of Renalytix's investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Renalytix AI suggests that some traders are interested. Renalytix's investing sentiment can be driven by a variety of factors including economic data, Renalytix's earnings reports, geopolitical events, and overall market trends.
  

Renalytix Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Renalytix can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a year ago at thelincolnianonline.com         
Analyzing SomaLogic Renalytix
news
over a year ago at news.google.com         
QA - How can AI assist in early detection of kidney disease - Medical Device Network
Google News at Macroaxis
over a year ago at news.google.com         
Renalytix Appoints Senior Executive Howard Doran as Chief Business Officer - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Decentralized OTC Desks Are Not Just for Crypto - Nasdaq
Google News at Macroaxis
over a year ago at news.google.com         
Renalytix gets KidneyIntelX included in major clinical guidelines - DIGITALLOOK
Google News at Macroaxis
over a year ago at benzinga.com         
Renalytix Clinical Advisory Board Formed to Support Broadening Use of KidneyintelX.dkd
benzinga news
over a year ago at globenewswire.com         
Renalytix Announces Middle East Distribution Agreement with Vector Pharma
Macroaxis News: globenewswire.com
over a year ago at news.google.com         
Why this AI diagnostics company is building a St. Pete lab - St Pete Catalyst
Google News at Macroaxis
over a year ago at news.google.com         
Renalytix Issue of Shares - Form 8-K - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Renalytix Commercializing First AI Kidney Disease Diagnostic Tool ... - Seeking Alpha
Google News at Macroaxis
over a year ago at benzinga.com         
Renalytix President Awarded 732K Worth of Stock Options
benzinga news
over a year ago at www.macroaxis.com         
Acquisition by Mclain Thomas H of 200000 shares of Renalytix subject to Rule 16b-3
Macroaxis News
over a year ago at Macroaxis         
Will Cigna Corp and Renalytix (USA Stocks:RNLX) make up?
Macroaxis News
over a year ago at globenewswire.com         
Acquisition by Coste Catherine of 190000 shares of Renalytix subject to Rule 16b-3
Macroaxis News: globenewswire.com
over a year ago at globenewswire.com         
Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association Scientific Sessio...
Macroaxis News: globenewswire.com
Far too much social signal, news, headlines, and media speculation about Renalytix that are available to investors today. That information is available publicly through Renalytix media outlets and privately through word of mouth or via Renalytix internal channels. However, regardless of the origin, that massive amount of Renalytix data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Renalytix news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Renalytix relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Renalytix's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Renalytix alpha.

Renalytix Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Renalytix AI Clinches 11.8M in Optimistic Fundraise - TipRanks
10/01/2024
2
Acquisition by Icahn School Of Medicine At Mount Sinai of 13366750 shares of Renalytix at 0.116 subject to Rule 16b-3
11/01/2024
3
Renalytix AI Sees Shift in Voting Rights Control - TipRanks
11/04/2024
4
Is Renalytix the best penny stock to buy today - MSN
12/03/2024
5
Insider Trading
12/06/2024

Additional Tools for Renalytix Stock Analysis

When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.